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Abstract
Background: Incorporating cognitive testing into routine clinical practice is a challenge in multiple sclerosis (MS), given the
wide spectrum of both cognitive and physical impairments people can have and the time that testing requires. Shortened paper
and verbal assessments predominate but still are not used routinely. Computer-based tests are becoming more widespread;
however, changes in how a paper test is implemented can impact what exactly is being assessed in an individual. The Symbol
Digit Modalities Test (SDMT) is one validated test that forms part of the cognitive batteries used in MS and has some
computer-based versions. We developed a tablet-based SDMT variant that has the potential to be ultimately deployed to patients’
own devices.
Objective: This paper aims to develop, validate, and deploy a computer-based SDMT variant, the Cognition Reaction (CoRe)
test, that can reliably replicate the characteristics of the paper-based SDMT.
Methods: We carried out analysis using Pearson and intraclass correlations, as well as a Bland-Altman comparison, to examine
consistency between the SDMT and CoRe tests and for test-retest reliability. The SDMT and CoRe tests were evaluated for
sensitivity to disability levels and age. A novel metric in CoRe was found: question answering velocity could be calculated. This
was evaluated in relation to disability levels and age for people with MS and compared with a group of healthy control volunteers.
Results: SDMT and CoRe test scores were highly correlated and consistent with 1-month retest values. Lower scores were seen
in patients with higher age and some effect was seen with increasing disability. There was no learning effect evident. Question
answering velocity demonstrated a small increase in speed over the 90-second duration of the test in people with MS and healthy
controls.
Conclusions: This study validates a computer-based alternative to the SDMT that can be used in clinics and beyond. It enables
accurate recording of elements of cognition relevant in MS but offers additional metrics that may offer further value to clinicians
and people with MS.
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Introduction
Background
Multiple sclerosis (MS) is an inflammatory demyelinating and
degenerative disease of the central nervous system and the most
common nontraumatic cause of disability in young adults
worldwide [1]. The dominant phenotype is characterized by
relapses (attacks) and remissions, known as relapsing-remitting
MS (RRMS). In the majority of those affected with RRMS, the
condition evolves, within 10 to 15 years, into secondary
progressive MS (SPMS). About 15% of people with MS develop
primary progressive MS (PPMS), characterized by progressive
neurological dysfunction from onset [2].
Motor impairment forms the most overt impact of MS but
cognitive impairment affects up to 40% of people with MS,
rising to 80% in those with the progressive forms of the disease
[3]. It has substantial impact on disability and can, when present
in isolation, limit employment prospects [4]. However, in the
early stages of MS, formal cognitive testing can show minimal
changes in a wide variety of domains [5]. Later, as the disease
advances, the picture becomes more coherent, with impairments
in speed of information processing, attention, episodic memory,
and executive function dominating. These impact independence
and mood and can lead to social isolation [6].
Cognitive testing itself can be demanding on patients, causing
difficulties for those with attentional disorders, fatigue, and
physical limitations [7]. The time and attention required in a
busy clinic environment makes test delivery in a routine context
a challenge for both patient and assessors. To this end, in MS,
a number of simplified tests of cognition have been developed
for clinical use. These include the Brief International Cognitive
Assessment for MS [8], the Brief Repeatable Battery of
Neuropsychological Tests [9], and the Minimal Assessment of
Cognitive Function in Multiple Sclerosis [10]. In most cases,
these tests are still largely paper- or apparatus-based exercises
completed in front of an assessor and take the form of a battery
of tests that incorporate multiple testing methodologies.
One common element of the MS testing batteries is the Symbol
Digit Modalities Test (SDMT) [11]. It assesses organic cerebral
dysfunction and has a proven history as an effective outcome
measure in a number of MS trials [10,11] and in other conditions
[12]. The SDMT consists of matching symbols against digits
within 90 seconds, the result being the total number of correct
answers. Participants are given a practice number of attempts
and then perform the timed assessment. The implementation of
the test typically takes 5 minutes, including instruction and
demonstration. The responses can be written or spoken out loud
and recorded by the assessor [13].
A number of electronic variants of the SDMT have been
developed [14,15], but as yet, they are not used routinely to
assess cognitive impairment [16]. Their implementation varies
from the original paper test, but the impact of these slight
variations is as yet unclear, as impairment in individuals with
MS can vary widely with different elements, such as fatigue,
which can slow reactions, and physical issues such as ataxia or
weakness, which can introduce further variability if a screen or
keyboard needs to be manipulated. This is a further challenge
if a test is to be administered without an assessor present.
However, the computer-based approaches have the potential to
offer additional information over the paper-based or oral
approaches, as additional metrics can be quantified and these
may enhance the information available from the test.
The United Kingdom Multiple Sclerosis Register (UKMSR)
was established in 2011 as a means of capturing real-world
evidence of living with MS in the United Kingdom. There are
comprehensive data on 11,387 people with MS registered on
the UKMSR via the internet and more than 13,000 consented
clinically via a network of National Health Service (NHS)
centers [17]. An online portal facilitates collection of
longitudinal patient-reported outcomes (PROs) and real-world
evidence of living with MS, but none of the instruments
currently capture cognitive function. Given the need to
understand in more depth the performance characteristics of
electronic testing and the key role of cognitive impairment in
MS, we developed an electronic variant of the SDMT that could
be implemented rapidly and routinely at clinical centers to
address this need. Ultimately, as an electronic register, if this
type of testing is validated, then it could be also carried out in
the patient’s home, which would also help patients who are
unable to physically attend clinics.
Objectives
This paper aims to develop, validate, and deploy a
computer-based SDMT variant, the Cognition Reaction (CoRe)
test, that can reliably replicate the characteristics of the
paper-based SDMT and assess its utility for deployment as a
meaningful measure to assess cognition in an MS population.
Methods
Population
All participants gave informed consent, and the study has ethical
approval from South West Central Bristol Ethics Committee
(16/SW/0194). Participants were recruited from Morriston
Hospital, Swansea Bay University Health Board and Charing
Cross Hospital, Imperial College Healthcare NHS Trust. The
people with MS that took part in the study were recruited at
either progressive MS teaching days or as part of their routine
visits to their respective hospitals. Demographic data and an
Expanded Disability Status Score (EDSS) [18] were recorded
at the time of testing. Healthy volunteers were recruited from
Swansea University Medical School and Imperial College
London to provide a control group of test scores with
anonymized demographic data. Healthy volunteers were
recruited from among the staff at the two clinical sites and
included a mix of staff and PhD students from Swansea
University. None of the healthy controls had MS and no one
approached refused. All participants had completed at least full
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formal secondary education. There were no declared visual
problems in the population.
CoRe Test App
The Cognition Reaction (CoRe) test was inspired by the SDMT;
however, there are some key differences. The CoRe test presents
9 different symbols displayed at the top of the screen, with
corresponding numbers, 1 through 9, underneath. The symbols
are randomized every time the app is launched, and the center
of the screen displays 2 symbols, the one to be identified now
and the next one. At the bottom of the screen, there are a number
of buttons labelled 1 through 9 that participants tap to match
the central symbol on the screen. Data recorded include the
number of symbols accurately tapped, as for the SDMT, but in
addition, CoRe automatically registers the time between
responses and the number of incorrect responses. Further details
of the app are presented in Multimedia Appendix 1 [19,20]. The
app is entirely self-contained, with no requirement for internet
access. The CoRe test app can be seen in Figure 1.
Figure 1. Cognitive Reaction test app shown running in portrait and landscape modes.
App Testing
For the MS population, participants first completed the paper
SDMT using the traditional written method, requiring the paper
test, a pen, and a stopwatch. Following this, participants were
handed an iPad and given an introduction by a researcher from
the UKMSR team, merely demonstrating the 2 orientations that
the device could be placed in. The orientation that participants
chose was not recorded as part of this assessment. They were
then invited to follow the written directions on the app. They
were first presented with a demonstration mode and encouraged
to run through at least once. A score of 4, which was displayed
on the screen, was required to progress to the main test. This
could be repeated if desired. Once ready, participants hit “start”
and were given 90 seconds to complete the test. A countdown
timer was displayed on the screen of the iPad. Visual acuity
was not formally assessed, and no participants claimed that they
could not see the icons on the tablet screen. Test environments
were controlled for noise and disturbance. Some participants
were retested 1 month later in the same environment to
determine the consistency of the results.
Statistical Analysis
Analysis was carried out using the Pandas library for Python
(version 3.773) [21] and the R statistical language (version
3.6.0; R Foundation for Statistical Computing) [22]. Graphs
and images were generated using Seaborn [23] and ggplot2
(version 3.0.0) [24]. Correlation was used to compare the
validity of the paper and electronic versions of the tests and the
test-retest reliability of the CoRe test. Pearson r was calculated
for test scores from the CoRe test and the SDMT, with mean
difference evaluated using a 2-tailed paired samples t test and
differences in variances compared using a Pitman-Morgan test
for paired samples. Intraclass correlation was also performed
on the first and second CoRe and SDMT test results. A
Bland-Altman analysis was used as an additional measure of
equivalency. The sensitivity of the CoRe and SDMT scores to
disability levels and age were measured using analysis of
variance (ANOVA) statistics, with post hoc Tukey tests used
to determine any significant differences between groups.
To utilize the additional data generated by the CoRe test, the
question answering velocity (QAV) was quantified as a measure
of cognitive function. This was defined as the total number of
correct answers given at a time divided by total current time
elapsed in the test (correct answers/seconds). Multivariate linear
regression was performed to determine if any relationship
existed between the QAV and the time period of the
questionnaire. The CoRe test lasts a total of 90 seconds, and
responses were divided into thirds to study the rates of change
over the first, second, and third sections of responses for each
patient. For analysis, EDSS scores were divided into 3
categories: low (EDSS of 0-2.5), medium (EDSS of 3-5.5), and
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high (EDSS of 6-10), as was age, with categories of 18-34 years,
35-54 years, and >55 years.
Results
Demographics
A total of 102 people with MS were recruited to the study (Table
1), of whom 30 returned within 1 month for a repeat test. All
patients were over 18 years of age and had no significant
comorbidities that would exclude them from being able to
complete the paper or CoRe tests. No participants were excluded
from the study, and none reported a relapse of MS at any point
in the testing. Mean age of the people with MS cohort tested
was younger than the overall MS Register population, with a
slightly lower proportion of patients with PPMS and SPMS
(Table 1). A total of 45 anonymous healthy controls were tested
during the development of the app; apart from not completing
an initial paper SDMT, conditions were similar to the MS
cohort. Both healthy controls and people with MS had completed
at least 12 years of education.
Table 1. Demographics of cohort and healthy controls undertaking the CoRe test. The UKMSR population is shown for comparison.
P valueCohort differenced,
t test (df)
Cohort differenced,
chi-square test (df)
CoRe cohort
(healthy controls)
CoReb cohort
(MSc)
Total UKMSRaCharacteristic
N/AN/AN/Ae4510211,387Total participants, n
.57N/A0.3 (1)Gender, n (% )
28 (62.2)70 (68.6)8387 (73.7)Female
17 (37.8)32 (31.4)3000 (26.3)Male
N/AN/AN/AMS type, n (%)
N/A86 (83.2)5988 (52.6)RRMSf
N/A5 (5.6)1492 (13.1)PPMSg
N/A9 (9.3)2945 (25.9)SPMSh
N/A2 (1.9)962 (8.4)Other
.0042.891 (145)N/A38.1 (11.9)44.0 (11.0)53.6 (11.8)Age (years), mean (SD)
N/AN/AN/AN/A34.6 (10.6)39.2 (10.3)Age at diagnosis (years), mean
(SD)
N/AN/AN/AN/A3.5 (1-8)6 (0-9.5)EDSSi, median (range)
aUKMSR: United Kingdom Multiple Sclerosis Register.
bCoRe: Cognitive Reaction.
cMS: multiple sclerosis.
dDifference between people with multiple sclerosis and healthy controls.
eN/A: not applicable.
fRRMS: relapsing-remitting multiple sclerosis.
gPPMS: primary progressive multiple sclerosis.
hSPMS: secondary progressive multiple sclerosis.
iEDSS: Expanded Disability Status Score.
CoRe Test in People With MS and Control Group:
Comparison of Total Correct Responses
The first set of CoRe test scores for people with MS were
compared with those of the healthy control group. Mean test
results for people with MS were 39.0 (SD 13.3), while mean
scores for the healthy control group were 56.1 (SD 15.9). An
unpaired t test found that people with MS had significantly
lower scores (t145=–6.769; P<.001), with no significant
difference in variance between the groups (F101,44=0.701;
P=.15).
CoRe Test and SDMT in People With MS: Comparison
of Total Correct Responses
People with MS completed both the CoRe test and SDMT
together on 2 occasions, 1 month apart. The first test response
distributions for the CoRe test and SDMT were normally
distributed (Shapiro-Wilk tests with P=.48 and P=.61,
respectively) and were strongly correlated (Pearson r100=0.800;
P<.001). First test participants scored a mean of 4.40 responses
lower for the CoRe test compared with the SDMT, as seen in
Table 2 (paired samples t101=5.390; P<.001), but there was no
significant difference in the variance (Pitman-Morgan test:
t100=–0.879; P=.38), with good agreement between tests (Figure
2). When the CoRe test and SDMT were repeated for a second
time, the mean CoRe test score was not significantly lower than
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the SDMT (1.4 responses difference; t29=0.954; P=.35). Again,
there was a strong correlation between the second CoRe test
and second SDMT (Pearson r28=0.842; P<.001). Table 2 shows
the baseline and retest responses for those who completed it.
Table 2. Baseline and retest SDMT and CoRe test total responses at baseline and retest 1 month later.
Score, mean (SD), rangeParticipants, nTest
Baseline
43.4 (12.6), 15-76102SDMTa
39.0 (13.3), 11-73102CoReb test
Retest
41.9 (14.6), 14-7630SDMT
40.5 (13.9), 20-7030CoRe test
aSDMT: Symbol Digit Modalities Test.
bCoRe: Cognitive Reaction.
Figure 2. Bland-Altman comparison of first CoRe test with paper SDMT scores. CoRe: Cognitive Reaction; SDMT: Symbol Digit Modalities Test.
CoRe Test and SDMT Test-Retest Reliability
First and second CoRe test and SDMT scores were evaluated
for test-retest reliability and scores at a 1-month interval. The
CoRe tests were normally distributed and demonstrated
consistency (Pearson correlation coefficient r=0.947; t28=15.60;
P<.001). Differences in means were normal (Shapiro-Wilk test
P=.81) and not significantly different (t29=–0.944; P=.35), with
equal variances (Pitman-Morgan t28=1.784; P=.09). The
intraclass correlation coefficient between the first and second
CoRe tests was found to be 0.942 (95% CI 0.882-0.0972;
F29,30=33.2; P<.001) (Figure 3).
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Figure 3. Intraclass correlation coefficients between the first and retested CoRe tests. CoRe: Cognitive Reaction; ICC: intraclass correlation coefficient;
MS: multiple sclerosis.
Test-retest correlations were observed in the same people
completing the SDMT at a 1-month interval. Scores were
normally distributed and consistent (Pearson correlation r=0.936;
t28=14.052; P<.001) and differences in means were normal
(Shapiro-Wilk test P=.44) and not significantly different
(t29=–0.919; P=.37), with equal variances (Pitman-Morgan
t28=–0.743; P=.46). The intraclass correlation coefficient
between the first and second SDMT tests was found to be 0.935
(95% CI 0.869-0.968; F29,30=29.6; P<.001).
CoRe Test Total Correct Response Score Is Impacted
by Age and Disability in MS, Whereas SDMT Is Only
Affected by Disability
We examined the impact of age, gender, and EDSS on the total
correct responses (Figure 4). An ANOVA for SDMT scores
with respect to age and EDSS found no significant impact of
age (aged 18-34 years: mean 48.1, SD 15.5; aged 35-54 years:
mean 43.2, SD 11.8; and 55+ years: mean 38.3, SD 9.0;
F2=1.036; P=.36), but significance for EDSS (low EDSS: mean
49.8, SD 12.9; medium EDSS: mean 41.4, SD 12.3; high EDSS:
mean 38.6, SD 9.8; F2=8.574; P<.001); post hoc Tukey tests
showed higher scores in those in the lowest EDSS category
compared with those in the highest EDSS category (P<.001)
and compared with the medium EDSS category (P=.01). No
significant difference was found between the low and medium
EDSS categories.
In contrast, an ANOVA for CoRe test scores showed a
significant difference in the total responses with age (aged 18-34
years: mean 48.6, SD 13.5; aged 35-54 years: mean 38.3, SD
11.6; and >55 years: mean 28.9, SD 9.8; F2=8.633; P<.001)
and EDSS (low EDSS: mean 47.4, SD 11.6; medium EDSS:
mean 36.8, SD 12.7; high EDSS: mean 32.1, SD 10.7;
F2=18.151; P<.001). Post hoc Tukey tests showed those in the
age group of 18 to 34 years had significantly higher scores than
those in the 34 to 54 years (P=.01) and 55+ years group
(P=.001), with no difference between the medium and high age
groups. The lowest EDSS category was associated with higher
CoRe test scores than both other groups (P<.001), with no
difference between the medium and high EDSS groups.
Gender was not found to be significant for either SDMT or
CoRe test scores.
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Figure 4. Mean SDMT and CoRe scores with age categories and EDSS scores. CoRe: Cognitive Reaction; EDSS: Expanded Disability Status Score;
SDMT: Symbol Digit Modalities Test.
Speed of Reaction (Question Answering Velocity)
Derived From the CoRe Test Increases Throughout
the Test and Correlates With Age, Gender, and
Disability
Due to the way data are acquired for the CoRe test, we were
able to measure the speed of reaction to each question and
calculate the QAV as correct answers over time elapsed
(seconds) continuously throughout the assessment. There was
a significant range of QAV over the time frame of the test in
people with MS, as illustrated in Figure 5, which shows the two
individuals with the lowest and highest scores in the CoRe test.
Breaking down the total correct answers into 3 sections also
allowed us to quantify the change in QAV over the course of
the CoRe test. Multiple linear regression models with the
variables age, gender, and EDSS in people with MS found that
QAV increased in each third of the test in people with MS and
healthy controls (Table 3).
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Figure 5. A polynomial regression of QAV for those people with MS with the lowest and highest scores in the cohort. CoRe: Cognitive Reaction;
EDSS: Expanded Disability Status Score; MS: multiple sclerosis; QAV: question answering velocity.
Table 3. Multivariate models in people with MS (R2=0.396; F5,3973=520.4; P<.001) and healthy controls (R
2=0.323; F4,2521=300.1; P<.001) for QAV
over the time frame of the Cognitive Reaction test, with additional covariates age and gender. EDSS scores are given for people with MS only.
QAV of healthy controlsQAVa of people with MSbVariable
P valueβ coefficient (95% CI)P valueβ coefficient (95% CI)
<.001.070 (0.056 to 0.085)<.001.045 (0.037 to 0.053)Second section compared to first
<.001.110 (0.094 to 0.123)<.001.071 (0.063 to 0.080)Third section compared to first
<.001–.008 (–0.007 to –0.008)<.001–.005 (–0.005 to –0.006)Age
<.001–.043 (–0.055 to –0.031)<.001.049 (0.041 to 0.056)Female gender
N/AN/Ad<.001–.017 (–0.015 to –0.019)EDSSc
aQAV: question answering velocity.
bMS: multiple sclerosis.
cEDSS: Expanded Disability Status Score.
dN/A: not applicable.
Both groups answered more quickly as the test progressed (the
control group at an even faster rate than people with MS), with
the second and third sections of their correct answers being
completed in less time than the first. The gradient is similar in
both populations (Figure 6). In both populations, increased age
was associated with slowing of QAV by 0.007 to 0.008
questions per second for each year increase in age. For control
participants, female gender was associated with a slowing of
QAV by 0.034 questions per second, whereas in people with
MS, female gender was associated with an increase in QAV of
0.049 questions per second. However, disability slowed QAV
by 0.017 questions per second for every increase in EDSS by
1 point (Table 3).
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Figure 6. Comparison of increase in speed between each test third for healthy and MS populations. CoRe: Cognitive Reaction; MS: multiple sclerosis;
QAV: question answering velocity.
We next directly compared the variables associated with CoRe
test QAV and the CoRe test total response score. A regression
using the variables age, gender, and EDSS score found that the
CoRe test QAV was significantly impacted by all 3 factors,
whereas the CoRe test score (total correct answers) found
significant impacts only from EDSS and age (Table 4).
Table 4. Impact of age, gender, and EDSS on total response score (R2=0.383; F3,98=20.3; P<.001) in people with MS cohort.
CoRea test scoreVariable
P valueβ coefficient (95% CI)
.002–2.103 (–3.390 to –0.808)EDSSb
<.001–.489 (–0.713 to –0.265)Age
.064.413 (–0.155 to 8.981)Female gender
aCoRe: Cognitive Reaction.
bEDSS: Expanded Disability Status Score.
Discussion
Summary of Findings
This study aims to validate an electronic variant of the SDMT,
comparing the CoRe test with the established paper-based
SDMT within an MS cohort in 2 independent UK centers,
examining its overall reliability and suitability. In addition, we
quantified an additional metric that can be extracted from the
electronic implementation. The total response scores for the
CoRe test were on average lower than the SDMT but showed
good correlation with the paper test, though there are clear
differences in responses across age groups. Having the
understanding that the CoRe performs similarly across these
deviations allows it to be compared with the paper-based test,
though it is not a like-for-like match. However, the consistency
of the test and its utility remain clear. The CoRe test showed
consistent responses over time and demonstrated similar
test-retest properties to the SDMT, as with other electronic
implementations [14]. These findings suggest that the CoRe
test is an appropriate alternative to measure of cognitive ability
as assessed by the SDMT.
We confirmed that a reduction in correct responses for both the
SDMT and CoRe test correlates with increasing disability, but
in addition, a reduction in correct responses correlates with
increasing age in people with MS. Using the advantages of an
electronic implementation, we were able to measure the QAV
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and found that both people with MS and healthy controls
increase their QAV throughout the test and also that in both
groups, an increased QAV correlates with younger age and male
gender. This implies these correlations are not associated with
MS-specific cognitive decline. However, increased QAV is also
associated with lower disability, only present in those with MS.
In our testing, increasing age showed a reduction in correct
responses over the test. This finding corresponds with other
SDMT testing in populations [25], and there is evidence for
older participants performing poorly over the duration of the
test, with studies showing decreased reaction times (about 0.5
ms/year) [26] in simple reaction-style tests in older people.
There is also the effect of older people’s familiarity with tablet
computers [27] that could have some impact on this. This will
be investigated in future testing.
There are a number of computer-based variants of the SDMT,
one of the first being the computerized Symbol Digit Modalities
Test (c-SDMT) [14], which showed excellent sensitivity in 119
people with MS versus 38 healthy controls, with people with
MS performing significantly worse than the healthy controls.
Use of the c-SDMT has not become widespread, most likely
due to the technology platform that it was developed on and the
stringent test description (Windows PC, 19-inch screen with
participant at 15 inches from the screen), making deployment
challenging. A more recent implementation of a computer-based
SDMT is the processing speed test (PST) [15], which was also
tested against a healthy control population and forms one
element of the Floodlight assessment tool [28]. The PST showed
similar results as we have demonstrated and has shown high
reliability when reproduced within Floodlight on patients’ own
devices. Small differences in implementation of the same
paper-based test can impact what is being tested and need to be
understood. The CoRe implementation requires the screen to
be touched, which adds a visuospatial element to the assessment,
and this will have an impact in some people with MS. It also
presents 2 symbols in random order as opposed to a standard
sheet of symbols; this change means that there is less likely to
be a learning effect on retesting. A key issue with
computer-based implementation is the impact of rapid hardware
and software development, which results in a need to develop
applications that can adapt to a changing environment. Another
issue is the variety of devices, such as desktops, laptops, and
smartphones, that are currently in use, especially if the test is
to be performed without an assessor present. CoRe has been
developed to run at multiple screen sizes and on different
devices, with an interface—two symbols seen at a time—that
is suited to a small screen. This will have to be tested separately.
Prior studies, and our results, show that data produced by
electronic tests are consistent, repeatable, and have utility to
clinicians, informing on a vital aspect of patient care [29]. The
scores on both paper SDMT and the CoRe test fall with
increasing disability. The CoRe test is more sensitive than the
SDMT to age, with the SDMT being only affected in populations
older than 55 years [27]. The electronic CoRe test allows greater
analysis of this effect, demonstrating slower mean response
times in higher ages and disability groups. There is some
evidence that there may be a gender difference in cognitive tests
[30], with males and females performing differently at various
ages in different test types. Notably, this is seen with visual
reaction times, and this would be consistent with the
implementation of the test presented here. The fact that this
extra variable of reaction time (QAV) can be measured as part
of the CoRe test could have clinical or research utility in the
future. Having additional quantifiable clinical measurement
information via a simple-to-implement and rapid test could
hopefully have some relevance to everyday clinical practice,
research, and medication trials. Benedict et al [13] state that the
current definition of “NEDA” (no evidence of disease activity)
is predicated on largely physical outcome measures, but
cognition is so fundamental to socialization, employment, and
quality of life beyond pure health care that a prolonged
measurement of cognitive aspects could add a compelling
dimension to our understanding of disease activity.
Limitations
We identified some limitations with this study. First, there were
few people with MS with progressive disease and advanced
disability, and we did not have complete directly measured
cognitive assessments. In addition, the population that took
1-month follow-up tests was limited, and we have only tested
this on a single type of device here. The 1-month period chosen
for retest represents the hospital visit pattern for some patients
on a particular disease-modifying therapy. Differing retest
periods should be tested in the future. Although testing was
performed in the presence of a researcher, they had little or no
input on the actual test itself—though this has been shown to
not have effect on these types of tests [31]. We also did not
consider the orientation of the device as having any effect. This
could also be incorporated into future testing on other devices.
Given that the CoRe test is consistent and repeatable, we intend
to test the app on other devices, including laptops and a variety
of smartphones. This will facilitate completion of the test away
from the clinic and will enable us to integrate the CoRe test into
the range of PROs captured by the UKMSR. Additionally, this
will allow us to carry out testing among participants with higher
disability and more progressive disease at different intervals to
ensure that the test maintains its reliability and repeatability.
We recognize that the CoRe is not an exact replacement for
SDMT. It is an entirely new test [32], but it is comparable and
measurable compared with the SDMT.
Conclusion
The CoRe implementation of the SDMT test is reliable and
correlates with the paper-based SDMT, while also offering the
additional metric of patient reaction time (QAV). This will allow
clinicians and researchers to capture important additional metrics
in people with MS, and potentially in other diseases, quickly
and reliably on existing tablet hardware.
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